1. Malaysia Stocks

  2. •

    Health services

  3. •

    Hospital/Nursing management
TMC Life Sciences Bhd.

TMC Life Sciences Bhd.

MMYX:TMCLIFE
0.42
MYR
+0.01
(+1.22%)
45.10P/E
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
0.09
0.11
0.1
0.08
0.09
0.1
0.11
0.12
0.14
0.18
0.2
0.2
- -
0.23
Basic EPS, GAAP
0.01
0.01
0.01
0.01
0.02
0.02
0.01
0.01
0.02
0.02
0.02
- -
- -
0.01
Free Cash Flow per Basic Share
0.01
0.01
- -
- -
- -
-0.01
-0.02
-0.05
-0.02
0.01
0.03
-0.01
- -
0.02
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.01
0.02
- -
- -
Book Value per Share
0.16
0.17
0.25
0.37
0.41
0.43
0.44
0.45
0.47
0.49
0.51
0.49
0.5
0.5
Tangible Book Value per Share
0.16
0.17
0.25
0.28
0.3
0.31
0.33
0.34
0.36
0.38
0.39
0.37
0.39
0.39
Basic Weighted Avg Shares
802
802
985
1,701
1,735
1,736
1,738
1,742
1,742
1,742
1,742
1,742
- -
1,742
Sales/Revenue/Turnover
71
86
103
128
152
169
195
201
244
311
346
346
393
393
Operating Margin (%)
2.5
6.76
4.05
9.45
12.37
14.42
15.37
12.37
12.34
13.79
15.37
2.21
6.2
6.2
Depreciation Expense
7
8
8
9
11
13
11
13
16
26
28
34
37
37
Net Income, GAAP
11
6
10
15
26
28
21
20
41
39
41
4
17
17
Effective Tax Rate (%)
- -
4.2
- -
27.41
4.07
16.02
45.17
26.81
- -
3.99
22.75
49.01
32.47
32.47
Profit Margin (%)
15.64
7.47
9.62
11.66
17.16
16.44
10.73
10.08
16.98
12.6
11.73
1.04
4.42
4.42
Working Capital
26
34
191
189
206
204
167
110
114
153
164
92
80
80
LT Debt
2
2
2
2
2
2
2
172
200
201
180
143
98
98
Total Equity
131
135
302
634
714
740
762
790
827
862
888
853
867
867
Return on Invested Capital (%)
- -
4.34
- -
1.88
2.68
2.84
2.21
2.12
- -
3.91
3.79
0.37
1.61
1.61
Return on Capital (%)
- -
4.84
- -
3.18
3.86
3.82
2.78
2.38
- -
4.56
4.47
0.79
2.19
2.19
Return on Common Equity (%)
8.81
4.84
4.54
3.18
3.86
3.82
2.78
2.61
5.12
4.65
4.65
0.41
2.02
2.02

Capital Structure

MYR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'26
ST Debt
47
47
47
LT Borrowings
119
108
97
LT Finance Leases
1
1
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,742
1,742
1,742
Market Capitalization
784
836
784

Working Capital

MYR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'26
Total Current Assets
202
195
197
Cash, Cash Equivalents & STI
113
118
108
Accounts Receivable, Net
64
58
42
Inventories
18
19
21
Total Current Liabilities
108
107
117
Payables & Accruals
- -
- -
- -
ST Debt
47
47
47
Deferred Revenue
- -
- -
- -

Growth Rates

MYR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
14.27%
1.94%
1.66%
Free Cash Flow
-101.77%
-112.23%
-330.46%
Net Income, GAAP
49.73%
78.72%
381.97%
Sales/Revenue/Turnover
14.62%
14.75%
13.74%
Total Cash Common Dividend
35.16%
66.61%
-91.6%

Quarterly Revenue

MYR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
92
94
86
74
346
2025
82
80
90
93
346
2026
100
103
90
99
393

Quarterly Earnings Per Share

MYR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.01
0.01
- -
0.02
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

MYR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.01
2025
- -
- -
- -
- -
0.02
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Savitha Dharan
Full Time Employees
1,217
Sector
Health services
Industry
Hospital/Nursing management
Address
No. 11, Jalan Teknologi Petaling Jaya SE Malaysia 47810
IPO Date
Oct 12, 2005
Website
tmclife.com
Similar Companies
Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP)
Max Healthcare Institute Ltd (NSE:MAXHEALTH)
Fortis Healthcare Ltd. (NSE:FORTIS)
Bangkok Dusit Medical Services Public Co. Ltd. (SET:BDMS)
Yatharth Hospital and Trauma Care Services Limited (NSE:YATHARTH)
HCA Healthcare, Inc. (NYSE:HCA)
Business
TMC Life Sciences Berhad (TMCLIFE:KLS) operates as an investment holding company that provides integrated healthcare services in Malaysia, with a focus on multi-disciplinary tertiary care and fertility treatments. The company offers comprehensive medical services through its Thomson Hospital Kota Damansara (THKD), including specialties such as obstetrics and gynaecology, cancer care, cardiology, orthopaedics, ENT, gastroenterology, urology, anesthesiology, dermatology, colorectal, internal medicine, and respiratory medicine; fertility services via TMC Fertility encompassing in-vitro fertilisation, preimplantation genetic testing, fertility preservation, laparoscopic surgery, surgical sperm retrieval, and donation programmes; fertility consultancy, laboratory, and embryology services; women's clinics; pharmacy services and products; traditional and complementary medicine; management support services; healthcare programme development, marketing, and management; and research and development activities, as well as property investment. Founded in 1994 and headquartered in Petaling Jaya, Selangor, it primarily serves patients in Malaysia with growing emphasis on medical tourism from Southeast Asia. TMC Life Sciences Berhad is a subsidiary of Sasteria (M) Pte. Ltd. and operates mainly through segments including Thomson Hospitals Sdn. Bhd. and IVF Technologies Sdn. Bhd. In recent developments, the company established a strategic partnership with OncoCare Medical Malaysia Sdn. Bhd. in September 2024 to enhance oncology services at THKD, contributing to revenue growth and improved profit before taxation in quarters through March 2025; it reported strong financial performance for FY2023/24 with revenue of RM364.14 million and cash balances of RM188.6 million, alongside optimism for FY2024/25 driven by expanded capacity, fertility business resurgence, and medical tourism; additionally, it declared dividends including a final single tier dividend of 0.4898 sen and a special dividend for the period ended March 2025, while pursuing sustainability goals like Net Zero by 2050.